
1. parasit vectors. 2018 jan 25;11(1):62. doi: 10.1186/s13071-018-2648-4.

mrna export apicomplexan parasite toxoplasma gondii: emerging divergent
components crucial pathway.

ávila ar(1)(2), cabezas-cruz a(3)(4)(5), gissot m(6).

author information: 
(1)instituto carlos chagas, fiocruz, rua algacyr munhoz mader, 3775. cic,
curitiba, pr, 81350-010, brazil. andrea.avila@fiocruz.br.
(2)umr bipar, animal health laboratory, anses, inra, enva, maisons alfort, cedex,
france. andrea.avila@fiocruz.br.
(3)umr bipar, animal health laboratory, anses, inra, enva, maisons alfort, cedex,
france.
(4)institute parasitology, biology center, czech academy sciences, české
budějovice, czech republic.
(5)faculty science, university south bohemia, české budějovice, czech
republic.
(6)university lille, cnrs, inserm, chu lille, institut pasteur de lille, u1019
- umr 8204 - ciil - centre d'infection et d'immunité de lille, f-59000, lille,
france. mathieu.gissot@pasteur-lille.fr.

control gene expression crucial parasite survival result 
a series processes regulated permit fine-tuning gene expression
in response biological changes the life-cycle apicomplexan
parasites. control mrna nuclear export key process eukaryotic cells
but poorly understood apicomplexan parasites. here, review recent
knowledge regarding process emphasis t. gondii. describe the
presence divergent orthologs discuss structural functional differences
in export factors apicomplexans eukaryotic lineages.
undoubtedly, use crispr/cas9 system high throughput screenings
associated discovery mrna nuclear export complexes proteomic
analysis contribute identify divergent factors. ligand-based or
structure-based strategies may applied investigate potential use of
these proteins targets new antiprotozoal agents.

doi: 10.1186/s13071-018-2648-4 
pmcid: pmc5785795
pmid: 29370868  [indexed medline]

